Company intelligence / Profile preview
CinnaGen
Tehran, Tehran, Irancinnagen.com ↗
- Ownership
- Private
- Employees
- ~2250
- Development stage
- Other
01
Overview
CinnaGen has commercialized over a dozen biosimilars across neurology/MS, oncology/hematology, endocrinology/growth disorders and autoimmune disease. It was the first MENA company to receive EMA GMP certification for its full-cycle biologics plant. The company continues to expand into new markets with ongoing clinical trials of additional biosimilars—including European studies—and has developed a recombinant COVID‑19 vaccine with international partners.
- Therapeutic areas
- RheumatologyOphthalmologyEndocrinologyImmunologyWomen's HealthOncologyRare DiseasesNeurologyInfectious Diseases
- Modalities
- BiosimilarsMonoclonal antibodies (mAbs)Recombinant proteinsTherapeutic enzymesSynthetic peptidesVaccines (e.g., recombinant COVID vaccine)Small molecules (limited; focus on biologics)
- Industry
- Biotech
02
Drug pipeline
8 assets7 more assets in the full pipeline.
03
Partnerships
licensing agreements with Fraunhofer Institute Germany for CinnoVexcollaboration with Vaxine Australia on SpikoGen COVID vaccinevarious academic/research collaborations
Beyond the preview
Go deeper on CinnaGen.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CinnaGen.